Ibio Inc (IBIO)

$1.42 +0.02 (1.43%)
Market Cap 69.55M
Revenue (ttm) 400,000.00
Net Income (ttm) -18.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,595.00%
Debt to Equity Ratio 0.00
Volume 470,200
Avg Vol 912,136
Day's Range N/A - N/A
Shares Out 49.68M
Stochastic %K 72%
Beta 1.27
Analysts Strong Sell
Price Target $5.53

Company Profile

iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cardiometabolic and obesity space. The company's technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies agai...

Industry: Biotechnology
Sector: Healthcare
Phone: 979 446 0027
Website: ibioinc.com
Address:
11750 Sorrento Valley Road, Suite 200, San Diego, United States
Scoty_D
Scoty_D Aug. 4 at 11:25 AM
$IBIO Tomny can you here me! Can you feel me near you!
0 · Reply
focafoca99
focafoca99 Aug. 4 at 11:22 AM
$IBIO designated Dr. Molly Carr as chief medical officer and granted her a 430,000-share stock option award. https://www.rapidticker.com/news/ibio-sec-filing-2e5258
0 · Reply
Retail_Lives_Matter
Retail_Lives_Matter Aug. 4 at 11:15 AM
$IBIO
0 · Reply
Retail_Lives_Matter
Retail_Lives_Matter Aug. 4 at 11:14 AM
$IBIO
0 · Reply
Retail_Lives_Matter
Retail_Lives_Matter Aug. 4 at 11:12 AM
$IBIO
1 · Reply
MicsMugz
MicsMugz Aug. 4 at 3:23 AM
$LGHL $IBIO Keep eyes 😆
0 · Reply
MicsMugz
MicsMugz Aug. 4 at 1:54 AM
$CENN $IBIO Look onto these
1 · Reply
MicsMugz
MicsMugz Aug. 4 at 1:52 AM
$IBIO Get in early Buy time
0 · Reply
MicsMugz
MicsMugz Aug. 4 at 1:47 AM
Get you watch lists. Prework sheets entrys exits setups,watch volume m.a catalyst always 10x volume then watch .Never chase. Ill show you the ways. $IBIO $SLV $GLD
0 · Reply
imjustjimmymoore
imjustjimmymoore Aug. 1 at 5:19 PM
$MRNA $IBIO $JNJ $BTC.X $XRP.X TIME TO JUMP IN THE BIOTECH SECTOR
0 · Reply
Latest News on IBIO
iBio appoints Molly Carr as chief medical officer

2026-08-04T13:15:57.000Z - 1 hour ago

iBio appoints Molly Carr as chief medical officer

LLY

iBio Strengthens Clinical Leadership with Appointment of Endocrinologist Molly Carr as Chief Medical Officer

Aug 4, 2026, 7:00 AM EDT - 4 hours ago

iBio Strengthens Clinical Leadership with Appointment of Endocrinologist Molly Carr as Chief Medical Officer

iBio announces new preclinical data from IBIO-610 study

2026-07-01T11:30:17.000Z - 4 weeks ago

iBio announces new preclinical data from IBIO-610 study

iBio Reports Single Dose of IBIO-610 Achieved Near-Complete Active Activin E Inhibition Through Eight Weeks in Obese NHP Study

Jul 1, 2026, 7:00 AM EDT - 4 weeks ago

iBio Reports Single Dose of IBIO-610 Achieved Near-Complete Active Activin E Inhibition Through Eight Weeks in Obese NHP Study

iBio initiated with an Outperform at Raymond James

2026-06-08T10:37:48.000Z - 2 months ago

iBio initiated with an Outperform at Raymond James

iBio, Inc. Transcript: Jefferies Global Healthcare Conference 2026

Jun 4, 2026, 11:40 AM EDT - 2 months ago

iBio, Inc. Transcript: Jefferies Global Healthcare Conference 2026

iBio to Participate in Upcoming Healthcare Investor Conferences

Jun 2, 2026, 4:01 PM EDT - 2 months ago

iBio to Participate in Upcoming Healthcare Investor Conferences

iBio doses first participant in IBIO-600 trial

2026-06-02T11:44:33.000Z - 2 months ago

iBio doses first participant in IBIO-600 trial

iBio Becomes a Clinical-Stage Company with First Participant Dosed in Phase 1 Clinical Trial of IBIO-600 in Adults with Obesity

Jun 2, 2026, 7:00 AM EDT - 2 months ago

iBio Becomes a Clinical-Stage Company with First Participant Dosed in Phase 1 Clinical Trial of IBIO-600 in Adults with Obesity

iBio, Inc. Slides: Corporate presentation

May 15, 2026, 7:00 AM EDT - 2 months ago

iBio, Inc. Slides: Corporate presentation

iBio reports Q3 EPS (7c), consensus (6c)

2026-05-12T21:36:01.000Z - 2 months ago

iBio reports Q3 EPS (7c), consensus (6c)

iBio Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update

May 12, 2026, 4:05 PM EDT - 2 months ago

iBio Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update

iBio, Inc. Earnings release: Q3 2026

May 12, 2026, 4:00 PM EDT - 2 months ago

iBio, Inc. Earnings release: Q3 2026

iBio, Inc. Quarterly report: Q3 2026

May 12, 2026, 4:00 PM EDT - 2 months ago

iBio, Inc. Quarterly report: Q3 2026

iBio, Inc. Transcript: Status update

Apr 8, 2026, 2:00 PM EDT - 4 months ago

iBio, Inc. Transcript: Status update

iBio receives regulatory clearance to initiate IBIO-600 trial in Australia

2026-04-08T11:12:57.000Z - 4 months ago

iBio receives regulatory clearance to initiate IBIO-600 trial in Australia

iBio Received Regulatory Clearance to Initiate Its Phase 1 Clinical Trial of IBIO-600 in Australia

Apr 8, 2026, 7:00 AM EDT - 4 months ago

iBio Received Regulatory Clearance to Initiate Its Phase 1 Clinical Trial of IBIO-600 in Australia

Biotech Alert: Searches spiking for these stocks today

2026-03-30T16:21:02.000Z - 4 months ago

Biotech Alert: Searches spiking for these stocks today

ACOG

iBio, Inc. Transcript: Study update

Mar 17, 2026, 4:00 PM EDT - 4 months ago

iBio, Inc. Transcript: Study update

iBio to provide update on cardiopulmonary program

2026-03-16T20:40:52.000Z - 5 months ago

iBio to provide update on cardiopulmonary program

iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

Mar 16, 2026, 4:30 PM EDT - 5 months ago

iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

iBio, Inc. Transcript: Leerink Global Healthcare Conference 2026

Mar 9, 2026, 4:20 PM EDT - 5 months ago

iBio, Inc. Transcript: Leerink Global Healthcare Conference 2026

iBio announces new preclinical data from study evaluating IBIO-610

2026-03-09T11:10:09.000Z - 5 months ago

iBio announces new preclinical data from study evaluating IBIO-610

iBio Reports Preclinical Body Composition Data from Obese Non-Human Primates Treated with IBIO-610, a Potential First-in-Class Treatment for Fat-Selective Weight Loss

Mar 9, 2026, 7:00 AM EDT - 5 months ago

iBio Reports Preclinical Body Composition Data from Obese Non-Human Primates Treated with IBIO-610, a Potential First-in-Class Treatment for Fat-Selective Weight Loss

iBio, Inc. Slides: Corporate presentation

Mar 9, 2026, 7:00 AM EDT - 5 months ago

iBio, Inc. Slides: Corporate presentation

iBio initiated with a Buy at JonesResearch

2026-03-02T21:34:02.000Z - 5 months ago

iBio initiated with a Buy at JonesResearch

iBio files $200M mixed securities shelf

2026-02-27T21:36:51.000Z - 5 months ago

iBio files $200M mixed securities shelf

Biotech Alert: Searches spiking for these stocks today

2026-02-27T16:00:56.000Z - 5 months ago

Biotech Alert: Searches spiking for these stocks today

iBio, Inc. Registration statement: Registration Filing

Feb 27, 2026, 7:00 AM EST - 5 months ago

iBio, Inc. Registration statement: Registration Filing

iBio, Inc. Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference

Feb 26, 2026, 2:00 PM EST - 5 months ago

iBio, Inc. Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference

iBio to Participate in Upcoming Investor Conferences

Feb 24, 2026, 7:00 AM EST - 5 months ago

iBio to Participate in Upcoming Investor Conferences

iBio reports Q2 EPS (9c), consensus (6c)

2026-02-10T21:13:10.000Z - 6 months ago

iBio reports Q2 EPS (9c), consensus (6c)

iBio Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update

Feb 10, 2026, 4:05 PM EST - 6 months ago

iBio Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update

iBio, Inc. Quarterly report: Q2 2026

Feb 10, 2026, 4:00 PM EST - 6 months ago

iBio, Inc. Quarterly report: Q2 2026

iBio, Inc. Earnings release: Q2 2026

Feb 10, 2026, 4:00 PM EST - 6 months ago

iBio, Inc. Earnings release: Q2 2026

iBio, Inc. Registration statement: Registration Filing

Jan 30, 2026, 7:00 AM EST - 6 months ago

iBio, Inc. Registration statement: Registration Filing

iBio prices 11.06M shares at $2.35 in private placement

2026-01-09T12:13:56.000Z - 7 months ago

iBio prices 11.06M shares at $2.35 in private placement

iBio Announces $26 Million Private Placement

Jan 9, 2026, 7:00 AM EST - 7 months ago

iBio Announces $26 Million Private Placement

Biotech Alert: Searches spiking for these stocks today

2026-01-08T17:16:04.000Z - 7 months ago

Biotech Alert: Searches spiking for these stocks today

iBio initiated with an Outperform at LifeSci Capital

2025-12-18T14:06:19.000Z - 8 months ago

iBio initiated with an Outperform at LifeSci Capital

ARWR WVE

iBio initiated with an Outperform at LifeSci Capital

2025-12-18T13:41:09.000Z - 8 months ago

iBio initiated with an Outperform at LifeSci Capital

Biotech Alert: Searches spiking for these stocks today

2025-12-11T16:45:34.000Z - 8 months ago

Biotech Alert: Searches spiking for these stocks today

CAMP

Biotech Alert: Searches spiking for these stocks today

2025-12-10T15:25:54.000Z - 8 months ago

Biotech Alert: Searches spiking for these stocks today

iBio, Inc. Transcript: Evercore ISI 8th Annual HealthCONx Conference

Dec 4, 2025, 8:45 AM EST - 8 months ago

iBio, Inc. Transcript: Evercore ISI 8th Annual HealthCONx Conference

iBio to Participate in the 8th Annual Evercore Healthcare Conference

Nov 24, 2025, 4:15 PM EST - 9 months ago

iBio to Participate in the 8th Annual Evercore Healthcare Conference

iBio, Inc. Slides: Corporate presentation

Nov 17, 2025, 7:00 AM EST - 9 months ago

iBio, Inc. Slides: Corporate presentation

iBio Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update

Nov 12, 2025, 4:01 PM EST - 9 months ago

iBio Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update

iBio, Inc. Earnings release: Q1 2026

Nov 12, 2025, 4:00 PM EST - 9 months ago

iBio, Inc. Earnings release: Q1 2026

iBio, Inc. Quarterly report: Q1 2026

Nov 12, 2025, 4:00 PM EST - 9 months ago

iBio, Inc. Quarterly report: Q1 2026

iBio, Inc. Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Nov 10, 2025, 8:30 AM EST - 9 months ago

iBio, Inc. Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Scoty_D
Scoty_D Aug. 4 at 11:25 AM
$IBIO Tomny can you here me! Can you feel me near you!
0 · Reply
focafoca99
focafoca99 Aug. 4 at 11:22 AM
$IBIO designated Dr. Molly Carr as chief medical officer and granted her a 430,000-share stock option award. https://www.rapidticker.com/news/ibio-sec-filing-2e5258
0 · Reply
Retail_Lives_Matter
Retail_Lives_Matter Aug. 4 at 11:15 AM
$IBIO
0 · Reply
Retail_Lives_Matter
Retail_Lives_Matter Aug. 4 at 11:14 AM
$IBIO
0 · Reply
Retail_Lives_Matter
Retail_Lives_Matter Aug. 4 at 11:12 AM
$IBIO
1 · Reply
MicsMugz
MicsMugz Aug. 4 at 3:23 AM
$LGHL $IBIO Keep eyes 😆
0 · Reply
MicsMugz
MicsMugz Aug. 4 at 1:54 AM
$CENN $IBIO Look onto these
1 · Reply
MicsMugz
MicsMugz Aug. 4 at 1:52 AM
$IBIO Get in early Buy time
0 · Reply
MicsMugz
MicsMugz Aug. 4 at 1:47 AM
Get you watch lists. Prework sheets entrys exits setups,watch volume m.a catalyst always 10x volume then watch .Never chase. Ill show you the ways. $IBIO $SLV $GLD
0 · Reply
imjustjimmymoore
imjustjimmymoore Aug. 1 at 5:19 PM
$MRNA $IBIO $JNJ $BTC.X $XRP.X TIME TO JUMP IN THE BIOTECH SECTOR
0 · Reply
Rower5oh
Rower5oh Aug. 1 at 2:20 PM
$IBIO https://www.linkedin.com/pulse/ibio-inc-factory-asset-joel-block-advantage-player--3d9lc?utm_source=share&utm_medium=member_ios&utm_campaign=share_via
0 · Reply
skitime
skitime Aug. 1 at 2:08 PM
$IBIO under $1 🤷‍♂️
0 · Reply
MicsMugz
MicsMugz Jul. 31 at 6:50 PM
$IBIO Buy
0 · Reply
Joelew22
Joelew22 Jul. 31 at 5:22 PM
$IBIO people always say stay patient. I am doing so at these levels. Hope Brenner and Ibio makes patience pay off
1 · Reply
hardbodyhank
hardbodyhank Jul. 30 at 12:21 PM
$IBIO junk
0 · Reply
MicsMugz
MicsMugz Jul. 29 at 10:23 PM
$IBIO Buy
0 · Reply
Retail_Lives_Matter
Retail_Lives_Matter Jul. 29 at 5:13 PM
$IBIO
0 · Reply
PandaTrade_
PandaTrade_ Jul. 28 at 8:18 PM
Seems like Volume is going in to APUS fast now! 🚀 APUS is breaking out with huge NEWS released! Only 400k shares remaining - People are just finding it. Don't be late to APUS, It's going parabolic. $BABA $LIDR $IBIO xoox
0 · Reply
Reacting_
Reacting_ Jul. 28 at 7:36 PM
$IBIO 👀
0 · Reply
Retail_Lives_Matter
Retail_Lives_Matter Jul. 28 at 7:30 PM
$IBIO bought 2K more in the 1.30’s today like a proper dumbass!
1 · Reply
skitime
skitime Jul. 28 at 4:35 AM
$IBIO
0 · Reply
TortillaDePatata
TortillaDePatata Jul. 27 at 8:06 PM
$IBIO Is the fat guy from the trial losing weight yet, or not? We need news!
2 · Reply